Remotely monitored “wearable” devices are helping to pave the way for evidence-based therapy and to facilitate personalized healthcare through predictive health analytics and medicine. The technologies are already having a significant impact, but they have the potential to be game-changers for cancer. However, a number of data-related hurdles need to be overcome in order to facilitate widespread adoption of remotely monitored clinical devices in cancer treatment.
Predicting Impact of Medicaid Program Changes on Health Centers and Investigating Disparities in Cancer Screening
Community health centers have been providing crucial health care services to low-income Americans for more than 50 years. Health centers now have more than 10,000 sites in rural and underserved communities in U.S. states and territories. However, proposed changes to the federal Medicaid program may impact the centers’ ability to continue to serve close to 26 million people who turn to them for health care.